APOA1 promotes tumor proliferation and migration and may be a potential pan-cancer biomarker and immunotherapy target
Open Access
- 14 March 2025
- journal article
- Published by Elsevier in Translational Oncology
- Vol. 55, 102344
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82171222)
This publication has 48 references indexed in Scilit:
- Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapyCell Reports, 2024
- Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factorsScience China Life Sciences, 2023
- A molecular classification of gastric cancer associated with distinct clinical outcomes and validated by an XGBoost-based prediction modelMolecular Therapy Nucleic Acids, 2022
- Sangerbox: A comprehensive, interaction‐friendly clinical bioinformatics analysis platformiMeta, 2022
- UALCAN: An update to the integrated cancer data analysis platformNeoplasia, 2022
- Navigating the DNA methylation landscape of cancerTrends in Genetics, 2021
- Therapeutic strategies involving survivin inhibition in cancerMedicinal Research Reviews, 2018
- DNA mismatch repair in cancerPharmacology & Therapeutics, 2018
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival AnalysesNeoplasia, 2017
- Hallmarks of Cancer: The Next GenerationCell, 2011